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Orthostatic stress testAbstract Aim of the work: The aim of this study was to evaluate clinically and electrophysiolog-
ically the autonomic nervous system changes associated with rheumatoid arthritis (RA).
Patients and methods: The present study included 25 patients with RA [22 women (88%)] and 30
apparently healthy control subjects [27 women (90%)]. A thorough clinical examination was carried
out. Disease activity and functional disability were assessed. Tests for assessment of autonomic func-
tions include active andpassive orthostatic stress tests, and sympathetic skin response (SSR).The pres-
ence of abnormality in 2 tests ormorewas a clue for the presence of autonomic neuropathy (AN). Sural
sensory nerve conduction study and posterior tibial motor nerve conduction study were done.
Results: There was a statistically signiﬁcant decrease in standing systolic and diastolic blood pres-
sure (BP) components of the active orthostatic stress test and SSR amplitude as well as statistically
signiﬁcant prolongation of SSR latency of RA patients when compared to control. Three patients
(12%) had clinical symptoms suggestive of AN; increased to 14 patients (56%)when orthostatic stress
tests and SSR were utilized. There were no statistically signiﬁcant differences between patients with
different disease activity score 28 with 4 variables grades of RA activity and SSR latency and ampli-
tude. Therewere no statistically signiﬁcant differences betweenpatientswith different StanfordHealth
Assessment Questionnaire Disability Index grades of RA functional disability and SSR latency and
amplitude.
Conclusions: Autonomic neuropathy is a common extra-articular manifestation of RA affecting
sympathetic and parasympathetic ﬁbers.
 2014 Production and hosting by Elsevier B.V. on behalf of Egyptian Society of Rheumatic Diseases.
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Rheumatoid arthritis (RA) is a chronic systemic inﬂammatory
autoimmune disorder. It affects principally the joints and is
usually accompanied by one or more of extra-articular mani-
festations as rheumatoid nodules, normochromic normocytic
anemia and neuropathy [1,2]. Neuropathies are estimated to
be the commonest neurological extra-articular feature. The
neuropathic affection among RA patients includes mononeu-
ropathy (entrapment neuropathy e.g. carpal tunnel syndrome),
mononeuritis multiplex, peripheral polyneuropathy and auto-
nomic neuropathy (AN) [3–5]. Autonomic neuropathy results
from the affection of the sympathetic and/or parasympathetic
nerve ﬁbers. Autonomic neuropathy manifests clinically as
cold, clammy, cyanotic extremities, peripheral vasospasm, pal-
pitation, orthostatic hypotension, syncopal attacks and sexual
dysfunction [6,7].
Autonomic neuropathy can be assessed by clinical and
electrophysiological tests. Clinically, AN can be detected by
active orthostatic stress test and passive orthostatic stress test
(tilt table test) [8]. Sympathetic skin response (SSR) is an
electrophysiological test which assesses autonomic dysfunction
[7,9].
There are scanty studies that assess autonomic nervous sys-
tem (ANS) affection electrophysiologically in RA [10]. The
aim of this study was to evaluate clinically and electrophysio-
logically the ANS changes associated with RA.2. Patients and methods
2.1. Patients
The present cross sectional study included 25 patients with RA
diagnosed according to the 2010 American College of Rheu-
matology/European League Against Rheumatism (ACR–EU-
LAR) classiﬁcation criteria for RA [which include the
presence or absence of rheumatoid factor (RF) and anti-citrul-
linated protein antibody (ACPA)] [11]. The patients were ac-
crued sequentially from those attending the Outpatient Clinic
of Physical Medicine, Rheumatology and Rehabilitation
Department, Main University Hospital, Alexandria Faculty
of Medicine. A control group of 30 apparently healthy volun-
teers were included. The volunteers consisted of medical staff,
their relatives and patients, relatives. The study was explained
to the participants and an informed consent was given by each.
The study had been approved by the ethics committee of the
Faculty of Medicine, Alexandria University, Egypt. Patients
with diabetes mellitus, endocrine disorders, metabolic disor-
ders, neurological disorders including sensory motor periphe-
ral neuropathy and carpal tunnel syndrome, patients who
had an overlap with other rheumatological illness and patients
on medical therapy known to affect ANS as tricyclic antide-
pressants were excluded.2.2. Methods
Patients were clinically evaluated. Clinical examination was
stressed on the musculoskeletal system and the detection of
extra-articular manifestations. Assessment of functional status
of RA patients was done using the Stanford HealthAssessment Questionnaire Disability Index (HAQ-DI) [12].
HAQ-DI score interpretation: HAQ-DI score of 0–1 repre-
sents mild disability, score of 1–2 represents moderate disabil-
ity and score of 2–3 represents severe disability [12].
Assessment of RA disease activity was done using disease
activity score 28 with 4 variables (DAS 28 with 4 variables)
[13]. DAS 28 with 4 variables score interpretation: DAS28 score
<2 represents not active, scores >2 and 63.2 represent mild
activity, scores >3.2 and 65.1 represent moderately active
and score >5.1 represents highly active [13]. Laboratory inves-
tigations were done for the patients and included ESR using
Westergren’s method and complete blood count [14,15].
Assessment of the ANS in both patients and control was
done by using the following tests and the presence of abnor-
mality in 2 tests or more was a clue for the presence of AN [4]:
(1) Active orthostatic stress test: It was done by measuring
the supine and standing blood pressure (BP) and heart
rate (HR). It was done by making the subject to lay
supine for 30 min then measure the BP and HR. Then
the subject stood upright for 10 min. A sustained
decrease in the systolic BP (P20 mmHg) or drop of
the diastolic BP (P10 mmHg) after standing for 5 min
(indication for sympathetic dysfunction) that is associ-
ated with or without an increase in the HR> 30 beats
per minute (indication for parasympathetic dysfunction)
suggests autonomic abnormality [8]. The test was done
in a calm atmosphere and after allowing the subject to
take a rest period of 30 min before starting the test.
(2) Passive orthostatic stress test (tilt table test): It was done
by making the subject to lay supine on a tilt table for
30 min then measure the BP and HR. Then the subject
was tilted upright for 10 min at an angle of 60–80.
Abnormal response was: (i) orthostatic hypotension:
when there was reduction of the systolic BP by
P20 mmHg or reduction of the diastolic BP by
P10 mmHg with or without syncope (indication for
sympathetic dysfunction) and/or (ii) postural orthostatic
tachycardia: when there was sustained increase of the
HR by >30 beats per minute or a sustained HR of
120 beats per minute (indication for parasympathetic
dysfunction) [8,16]. The test was done under the same
circumstance of the active orthostatic stress test and in
the same room. The subject was allowed to take a rest
period of 30 min before starting the test.
(3) Sympathetic skin response of the hand was done as a
measurement of the sympathetic function. It was con-
ducted on a Nihon Kohden Neuropack MEB-7102
mobile unit with a two channel evoked potential/EMG
measuring system (Nihon Kohden Corporation, Tokyo,
Japan). Skin temperature at the site of the recording
electrode was maintained around 31–32 C by the mean
of hot packs. The SSR was performed by the same
examiner. The hand was manually ﬁxed by the examiner
to reduce movement artifacts. The ground electrode was
placed between the recording electrodes distally and the
stimulation site proximally. An active recording surface
disc electrode was attached to the palm and the refer-
ence surface disc electrode was attached to the dorsum
of the hand. The used stimuli were single electrical
stimulus at the wrist (over the median nerve) contralat-
eral to the recording side. The stimuli were delivered
Table 1 Clinical features of rheumatoid arthritis patients.
Clinical features of RA patients Patients (n= 25)
Mean ± SD Range
Age of onset (years) 37.16 ± 10.12 20–58
Duration of the disease (years) 6.20 ± 3.92 1–15
HAQ-DI 1.03 ± 0.58 0.16–2.40
28TJC 15.92 ± 7.84 4–28
28SJC 6.48 ± 4.90 1–18
ESR (mm/1st hr) 48.76 ± 18.40 25–110
Patients’ global assessment of disease
activity
5.64 ± 2.32 1–10
DAS28 with 4 variables 4.04 ± 0. 84 2.7–5.3
n (%)
RF positivity 22 88
ACPA positivity 15 60
Patients with extra-articular
manifestations
19 76
Keratoconjuctivitis sicaa 17 68
Normochromic normocytic anemia 19 76
Dysautonomic symptoms 3 12
Orthostatic hypotension 3 12
Syncopal attacks 1 4
Rheumatoid nodules 2 8
RA: rheumatoid arthritis; HAQ-DI: Stanford Health Assessment
Questionnaire Disability Index; 28SJC: 28 swollen joint count;
28TJC: 28 tender joint count; ESR: erythrocyte sedimentation rate;
DAS28: disease activity score 28; RF: rheumatoid factor; ACPA:
anti-citrullinated protein antibody; SD: standard deviation; n (%):
number of patients (percentage).
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habituation. The bipolar stimulator had a production
current ability of 50 mA. The stimulation frequency
was 0.1 Hz and pulse duration was 0.2 ms. The sweep
speed was 0.5 s/division and the sensitivity was 50–
200 uV/division. The ﬁlter bandwidth was 1 Hz–3 kHz.
Responses were recorded four times and were superim-
posed to ensure reproducibility. Measurements included
the elicitability of the response, latency and amplitude.
The latency was measured from the stimulus artifact
onset to the onset of initial negative deﬂection expressed
in seconds. The amplitude was measured from the base-
line to the negative peak expressed in microvolt. Abnor-
mality of SSR (sympathetic dysfunction) was deﬁned as
absent or delayed latency and/or low amplitude exceed-
ing the cut-off point at which highest diagnostic
accuracy was reached that was estimated using the
mean + 2SD for latency and mean  2SD for ampli-
tude [17].
Both components of the ANS were assessed as follows:
(a) The sympathetic nervous system was assessed by using
the BP changes in response to postural changes (i.e.
active and passive orthostatic stress tests) and SSR [18].
(b) The parasympathetic nervous system was assessed by
HR changes in response to postural changes (i.e. active
and passive orthostatic stress tests) [18].
Sural sensory nerve conduction study and posterior tibial
motor nerve conduction study were done to both patients
and control for assessment of the peripheral nerve [19].
Statistical analysis of data was done by using the Statistical
Package of Social Science (SPSS version 17) software. Descrip-
tive measures [count, frequency, minimum, maximum, median,
mean and standard deviation (SD)] as well as analytic mea-
sures (qualitative data were analyzed using chi-square for inde-
pendent groups; quantitative data were analyzed using Mann
Whitney test to compare between two independent groups
and Kruskel-Wallis test to compare between more than two
independent samples and correlation was conducted using
Spearman’s correlation test) were used. Statistical signiﬁcance
was assigned to any P value at 60.05. The cut off value of the
electrophysiological studies was equal to the mean plus two
standard deviations for SSR latency and was equal to the mean
minus two standard deviations for SSR amplitude.
3. Results
The present study included 25 patients with RA [22 women
(88%) and 3 men (12%)]. Their mean age was
43.96 ± 11.28 years (ranged from 21 to 64 years). The control
group consisted of 30 individuals [27 women (90%) and 3 men
(10%)]. Their mean age was 40.23 ± 11.14 years (ranged from
22 to 65 years). There were no statistically signiﬁcant differ-
ences between patients and controls as regards gender
(P= 0.813) and age (P= 0.181).
The clinical data of the patients are summarized in Table 1.
As regards HAQ-DI, 13 patients (52%) had mild disability, 10
patients (40%) had moderate disability and 2 patients (8%)
had severe disability. The patient group covered the 3 gradesof disability. Diseases activity assessed by DAS28 with 4 vari-
ables showed that there were 9 patients (36%) with mild activ-
ity, 13 patients (52%) with moderate activity and 3 patients
(12%) with high activity. The patient group covered the 3
grades of RA disease activity. All patients who had extra-artic-
ular manifestation [19 patients (76%)] were RF positive. All
patients who had ACPA positive [15 patients (60%)] had ex-
tra-articular manifestation. There were no statistically signiﬁ-
cant differences between patients and controls as regards
sural nerve amplitude (P= 0.389), sural nerve conduction
velocity (P= 0.642), tibial nerve amplitude (P= 0.813) and
tibial nerve conduction velocity (P= 0.116) which exclude
the presence of sensory motor peripheral polyneuropathy
among the RA patient group.
All control individuals had normal response to the active
and passive orthostatic stress tests. The frequency of abnor-
malities in both active and passive orthostatic stress tests
among RA patients is tabulated in Table 2. The standing sys-
tolic BP and standing diastolic BP components of the active
orthostatic stress test were signiﬁcantly decreased among pa-
tient group compared to control group (Table 3). The cut-off
point of the SSR latency was 1.44 s and that of SSR amplitude
was 40.15 lV. SSR was elicited in all patients and control. The
frequency of abnormalities in SSR latency and amplitude
among RA patients is tabulated in Table 2. SSR latency was
signiﬁcantly prolonged among patient group compared to con-
trol group. SSR amplitude was signiﬁcantly decreased among
patient group compared to control group (Table 4).
There were 3 patients (12%) that had symptoms suggestive
of AN (Table 1). The dysautonomic symptoms included
Table 2 Frequency of abnormalities in orthostatic stress tests
and sympathetic skin response among rheumatoid arthritis
patients.
Tests assessing ANS Frequency of abnormalities
[n (%)]
Active orthostatic stress test
Abnormal response 11 (44)
Orthostatic hypotension 11 (44)
Postural orthostatic tachycardia 2 (8)
Passive orthostatic stress test
Abnormal response 14 (56)
Orthostatic hypotension 14 (56)
Postural orthostatic tachycardia 6 (24)
SSR
Abnormal SSR 18 (72)
Prolonged SSR latency 15 (60)
Low SSR amplitude 14 (56)
ANS: autonomic nervous system; SSR: sympathetic skin response;
n (%): number of patients (percentage).
160 E. Saba, H. Sultanorthostatic hypotension and syncopal attacks. All these
patients had 2 or 3 abnormal tests assessing ANS. The number
of patients with AN increased to 14 patients (56%) when car-
diovascular autonomic function tests (active orthostatic stress
test and passive orthostatic stress test) and SSR were utilized [8
patients (32%) had 3 abnormal tests and 6 patients (24%) had
2 abnormal tests respectively]. All of them had sympathetic
dysfunction and 24% of patients had parasympathetic
dysfunction. All these patients had other extra-articular man-
ifestations and all of them had positive RF and ACPA.Table 3 Comparison between rheumatoid arthritis patients and co
Active orthostatic stress test parameters Patients (n= 25)
Supine systolic BP (mmHg)
Median 120
Mean ± SD 117.72 ± 10.50
Range 100–135
Supine diastolic BP (mmHg)
Median 75
Mean ± SD 72.72 ± 11.04
Range 55–95
Supine HR (beat/min)
Median 66
Mean ± SD 67.80 ± 8.64
Range 54–82
Standing systolic BP (mmHg)
Median 100
Mean ± SD 101.40 ± 13.95
Range 80–135
Standing diastolic BP (mmHg)
Median 65
Mean ± SD 66.12 ± 9.94
Range 50–88
Standing HR (beat/min)
Median 82
Mean ± SD 82.28 ± 11.55
Range 60–105
BP: blood pressure; HR: heart rate; SD: standard deviation; n: number o
* P is signiﬁcant at 60.05.There were no statistically signiﬁcant differences between
patients with different DAS28 grades of RA activity and
SSR latency (P= 0.625) and amplitude (P= 0.350). There
were no statistically signiﬁcant differences between patients
with different HAQ-DI grades of RA functional disability
and SSR latency (P= 0.128) and amplitude (P= 0.759).
There was a statistically signiﬁcant negative correlation be-
tween standing systolic BP and standing diastolic BP compo-
nents of active orthostatic stress test, and patient’s global
assessment of disease activity (r= 0.423, P= 0.035;
r= 0.532, P= 0.006 respectively). Otherwise, there was no
statistically signiﬁcant correlation between other different ac-
tive orthostatic stress test parameters and RA disease duration,
DAS28 score, DAS28 components and HAQ-DI (all had
P> 0.05). There was no statistically signiﬁcant correlation be-
tween SSR latency and amplitude, and RA disease duration,
DAS28 score, DAS28 components and HAQ-DI (all had
P> 0.05).
4. Discussion
The aim of the current study was to assess the ANS changes
associated with RA from the clinical and electrophysiological
point of view.
In the present study, both components of the ANS were as-
sessed including the sympathetic and the parasympathetic ner-
vous systems. The sympathetic nervous system was assessed by
using the BP changes in response to postural changes and SSR.
The parasympathetic nervous system was assessed by HR
changes in response to postural changes [18].ntrols as regards the active orthostatic stress test.
Control (n= 30) Z P
120 0.830 0.407
119.90 ± 9.69
100–135
79 1.111 0.267
75.46 ± 9.47
55–90
72.5 1.484 0.138
72.00 ± 9.04
58–86
110 2.950 0.003*
111.36 ± 11.38
90–135
75 2.355 0.019*
71.80 ± 7.77
55–80
81.5 0.779 0.436
79.83 ± 10.71
60–97
f individuals; Z= value of Mann–Whitney.
Table 4 Comparison between rheumatoid arthritis patients and controls as regards the sympathetic skin response parameters.
SSR parameters Patients (n= 25) Control (n= 30) Z P
Latency (s)
Median 1.39 1.09 3.584 <0.0001*
Mean ± SD 1.32 ± 0.27 1.06 ± 0.19
Range 0.75–1.70 0.69–1.46
Amplitude (lV)
Median 38.6 128.05 6.009 <0.0001*
Mean ± SD 39.58 ± 20.20 125.41 ± 42.63
Range 12.80–91.90 53.30–199.00
SSR: sympathetic skin response; SD: standard deviation; n: number of individuals; Z= value of Mann–Whitney.
* P is signiﬁcant at 60.05.
Autonomic nervous system changes associated with RA 161Orthostatic stress test assesses the BP and HR changes
associated postural changes in the body position from supine
to standing. These changes are mediated by sympathetic and
parasympathetic nerve ﬁbers. During standing from supine po-
sition (actively or passively), there is pooling of blood in the
veins of the lower limbs and splanchnic circulation results in
decrease in the stroke volume. This leads to a slight decrease
in the BP and a slight increase in the HR associated with vaso-
constriction of the blood vessels of the lower limbs and
splanchnic circulation. This is mediated by reﬂex sympathetic
stimulation and parasympathetic inhibition. Passive ortho-
static stress test is more sensitive than the active orthostatic
stress test. This test is characterized by minimizing the com-
pensatory response of active muscle contraction of the lower
limbs which can affect the result of the active orthostatic stress
test by reducing lower limb pooling of blood. In autonomic
neuropathy, this reﬂex is abnormal which leads to the abnor-
mal orthostatic stress test (both active and passive) [8].
In the current study, the standing systolic BP and standing
diastolic BP components of the active orthostatic stress test
were signiﬁcantly decreased among patient group compared
to control group. There was also a statistically signiﬁcant in-
crease in the SSR latency and a statistically signiﬁcant decrease
in the SSR amplitude among RA patients. This indicates the
presence of sympathetic dysfunction among RA patients.
In the present study, there were no statistically signiﬁcant
correlation between SSR latency and amplitude as regards
RA disease duration, DAS28 score, DAS28 components and
HAQ-DI. This means that the pathogenic mechanism respon-
sible for the development of AN might differ from that of RA
joint involvement.
There was a negative correlation between the standing sys-
tolic BP and standing diastolic BP components of active ortho-
static stress test, and patient’s global assessment of disease
activity which is a component of DAS 28 with 4 variables. This
correlation was unexplained as there was no signiﬁcant corre-
lation between the standing systolic BP and standing diastolic
BP with DAS28 score and HAQ-DI.
There were 56% of patients with AN. All of them had sym-
pathetic dysfunction and 24% of patients had parasympathetic
dysfunction. This indicates that AN among RA patients af-
fects both ANS components: sympathetic and parasympa-
thetic nervous systems. This could not be explained by the
limited mobility of RA patients as 92% of them had mild or
moderate functional disability assessed by HAQ-DI. Their
functional disability was not so severe to the degree that can
affect the BP and HR assessed by orthostatic stress test.All these patients had other extra-articular manifestations
and all of them had positive RF and ACPA. The presence of
RF and ACPA is an indicator of severe RA disease and is asso-
ciated with extra-articular manifestations including AN [3,20].
The present study is in agreement with Turesson et al. [20] and
De Rycke et al. [21]. Turesson et al. [20] reported that RF is
strongly associated with extra-articular manifestations in RA
patients and they found a statistically signiﬁcant difference in
RF titers between patients with extra-articular manifestations
versus those without extra-articular manifestations. De Rycke
et al. [21] reported that the presence of extra-articular manifes-
tations in RA is associated with RF.
The current study is in agreement with other studies that as-
sessed the ANS among RA patients [4,22–26]. Jale et al. [22]
assessed the ANS among RA patients. Their study showed
that there were frequent abnormalities in SSR and R-R inter-
val variation tests in patients with RA whether there was a
clinical symptom of autonomic dysfunction or not. Geenen
et al. [23] found that there was diminished ANS response sec-
ondary to AN in RA of recent onset and mainly in patients
with more severe pain. Edmonds et al. [24] reported that
14.8% of RA patients had symptoms suggesting ANS dysfunc-
tion. They detected abnormalities in parasympathetic cardio-
vascular reﬂexes in 33% of their RA patients including those
who had symptoms of autonomic dysfunction. More than
50% of their patients with abnormal tests for ANS had evi-
dence of peripheral neuropathy. Toussirot et al. [4] investi-
gated autonomic dysfunction among RA patients by three
cardiovascular tests which were HR variations in deep breath-
ing, valsalva maneuver and orthostatic change in posture.
They found that 60% of their 50 RA patients had ANS dys-
function. No patients showed neurological sign or autonomic
sign. They reported that there was no obvious correlation be-
tween ANS dysfunction in RA and markers of inﬂammation,
presence of RF, duration of disease or degree of joint destruc-
tive lesions [4]. Gokoglu et al. [25] reported that all their RA
patients were asymptomatic for AN and had normal neurolog-
ical examination ﬁndings. They assessed the sympathetic func-
tions by systolic BP response to standing and diastolic BP
response to isometric exercise and SSR. They also assessed
parasympathetic functions by HR variation with deep breath-
ing, HR response to standing and R–R interval variation mea-
surements. They reported that all the assessed parameters were
signiﬁcantly lower in RA patients than in control subjects [25].
Yadav et al. [26] reported that HR variability was signiﬁcantly
altered in patients with RA and independently associated with
disease activity.
162 E. Saba, H. SultanThe present study is not in accordance with Bekkelund et al.
[27] and Vlcek et al. [28]. Bekkelund et al. [27] found no cardio-
vascular ANS abnormality in their 43 RA patients who had no
ANS symptoms. Vlcek et al. [28] reported normal reactivity of
the sympathoneural system during orthostatic challenge in RA
patients younger than 40 years. The current study is not in
accordance with these two studies due to difference in the inclu-
sion and exclusion criteria of RA patients’ selection and differ-
ences in the deﬁnition of ANS abnormalities.
The pathogenesis of AN in RA has not been determined
yet. It was postulated to be due to abnormalities in the sympa-
thetic postganglionic function. This is secondary to the devel-
opment of circulating autoantibodies directed to nerve growth
factor, sympathetic cervical ganglia, vagus nerve and the gan-
glionic acetylcholine receptors [29–31]. This can be the expla-
nation for loss of sympathetic nerve ﬁbers in the inﬂamed
joints of RA patients as found in some studies [32–34]. Also,
it was found that high level of intrathecal IL-1beta and possi-
bly other inﬂammatory mediators in the CNS are of impor-
tance for the reduced vagal function in RA [35]. Autonomic
neuropathy can occur with secondary amyloidosis. This was
reported in a case of RA with AN resulting in severe and dis-
abling orthostatic hypotension. Extensive amyloid deposits
were found throughout the ANS in this case [36].
It is important to take AN into consideration during deal-
ing with RA patients. Autonomic neuropathy is usually sub-
clinical in most cases. It needs speciﬁc tests to diagnose it.
Some of them are clinical tests as the orthostatic stress test (ac-
tive and passive types) and others are electrophysiological tests
which are available in many electrodiagnosis laboratories.
Autonomic neuropathy can be the initial extra-articular man-
ifestation in RA patient so its presence affects the prognosis of
RA. The presence of AN affects the management of RA pa-
tients with other comorbidities during prescription of drugs
that have effects on the cardiovascular ANS which should be
taken into consideration [6].
The current study had two limitations. First one was the
small number of RA patients. This was secondary to the wide
range of exclusion criteria present in this study which limits the
number of the patients. Second one was the few number of
men participated in the study which might reduce the general-
izability of the results.
Autonomic neuropathy is a common extra-articular mani-
festation of RA which is usually subclinical. Autonomic neu-
ropathy in RA usually affects both the sympathetic and
parasympathetic components of the ANS. It needs to be taken
into consideration and to be diagnosed by speciﬁc tests clini-
cally and electrophysiologically for better management of
RA patients.
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